Erfordert Authentifizierung

Platelet additive solutions: current status

   | 01. Apr. 2020

Zitieren

Holme S. Effect of additive solutions on platelet biochemistry. Blood Cells 1992;18:421–30.Search in Google Scholar

Holme S. Platelet storage in liquid environment. Transfus Sci 1994;15:117–30.10.1016/0955-3886(94)90086-8Search in Google Scholar

Högman CF. Aspects of platelet storage. Transfus Sci 1994;15:351–5.10.1016/0955-3886(94)90167-8Search in Google Scholar

Murphy S. The efficacy of synthetic media in the storage of human platelets for transfusion. Transfus Med Rev 1999;13:153–63.10.1016/S0887-7963(99)80029-7Search in Google Scholar

Gulliksson H. Additive solutions for the storage of platelets for transfusion. Transfus Med 2000; 10:257–64.10.1046/j.1365-3148.2000.00262.xSearch in Google Scholar

Gulliksson H. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003;17:209–15.10.1016/S0887-7963(03)00020-8Search in Google Scholar

Holme S, Heaton WA. In vitro platelet ageing at 22°C is reduced compared to in vivo ageing at 37°C. Br J Haematol 1995;91:212–8.10.1111/j.1365-2141.1995.tb05272.x7577636Search in Google Scholar

Oksanen K, Ebeling F, Kekomäki R, et al. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang 1994;67:356–61.10.1111/j.1423-0410.1994.tb01273.x7701806Search in Google Scholar

van Rhenen DJ, Vermeij K, Kappers-Klunne R, et al. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats. Transfusion 1995;35:50–3.10.1046/j.1537-2995.1995.35195090662.x7998070Search in Google Scholar

Eriksson L, Kristensen J, Olsson K, et al. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets: comparison between platelet concentrates derived from pooled buffy coats and apheresis. Vox Sang 1996;70:69–75.10.1111/j.1423-0410.1996.tb01296.x8801766Search in Google Scholar

Strindberg J, Berlin G. Transfusion of platelet concentrates: clinical evaluation of two preparations. Eur J Haemotol 1996;57:307–11.10.1111/j.1600-0609.1996.tb01382.x8982294Search in Google Scholar

Turner VS, Mitchel SG, Hawker RJ. More on the comparison of Plasma-Lyte A and PAS-2 as platelet additive solutions. Transfusion 1996;36:1033–4.10.1046/j.1537-2995.1996.36111297091750.x8937416Search in Google Scholar

Högman CF, Eriksson L, Wallvik J, et al. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5 CPD Erythro-sol Opti System. Vox Sang 1997;73:212–9.Search in Google Scholar

de Wildt-Eggen J, Nauta S, Schrijver JG, et al. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomised study. Transfusion 2000;40:398–403.10.1046/j.1537-2995.2000.40040398.x10773049Search in Google Scholar

Shanwell A, Diedrich B, Falker C, et al. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days. Transfusion 2006;46:973–9.10.1111/j.1537-2995.2006.00830.x16734814Search in Google Scholar

Murphy S. Radiolabeling of PLTs to assess viability: a proposal for a standard. Transfusion 2004;44: 131–3.10.1111/j.0041-1132.2003.00607.x14692979Search in Google Scholar

Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997;37:423–35.10.1046/j.1537-2995.1997.37497265344.x9111281Search in Google Scholar

van Rhenen, D, Gulliksson H, Cazenave JP, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003;101:2426–33.10.1182/blood-2002-03-093212456508Search in Google Scholar

McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation. The SPRINT Trial. Blood 2004;104: 1534–41.10.1182/blood-2003-12-444315138160Search in Google Scholar

Snyder E, McCullough J, Slichter JS, et al. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005;45:1864–75.10.1111/j.1537-2995.2005.00639.x16371039Search in Google Scholar

Janetzko K, Cazenave JP, Klüter H, et al. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integration set. Transfusion 2005;45:1443–52.10.1111/j.1537-2995.2005.00550.x16131376Search in Google Scholar

van Rhenen, DJ, Gulliksson H, Cazenave JP, et al. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution. Transfus Med 2004;14:289–95.10.1111/j.0958-7578.2004.00516.x15285725Search in Google Scholar

Gewirtz AM, Schick B. Platelet production and function: megakaryocytopoiesis. In: Colman RW, Hirsh J, Marder VJ, et al., eds. Hemostasis and thrombosis. 3rd ed. Philadelphia: JB Lippincott, 1994:353–96.Search in Google Scholar

Ringwald J, Walz S, Zimmermann R, et al. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality. Vox Sang 2005;89:11–8.10.1111/j.1423-0410.2005.00645.x15938735Search in Google Scholar

Ringwald J, Duerler T, Frankow O, et al. Collection of hyperconcentrated platelets with Trima Accel. Vox Sang 2006;90:92–6.10.1111/j.1423-0410.2005.00721.x16430666Search in Google Scholar

Sweeney J, Kouttab N, Holme S, et al. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion 2006;46:835–40.10.1111/j.1537-2995.2006.00804.x16686852Search in Google Scholar

Holme S, Heaton WA, Courtright M. Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sang 1987;53:214–20.10.1111/j.1423-0410.1987.tb05069.x3125686Search in Google Scholar

Gulliksson H, Sallander S, Pedajas I, et al. Storage of platelets in additive solutions: a new method for storage using sodium chloride solution. Transfusion 1992;32:435–40.10.1046/j.1537-2995.1992.32592327717.x1626346Search in Google Scholar

Shimizu T, Murphy S. Roles of acetate and phosphate in the successful storage of platelet concentrates prepared with an acetate-containing additive solution. Transfusion 1993;33:304–10.10.1046/j.1537-2995.1993.33493242637.x8480350Search in Google Scholar

Bertolini F, Murphy S, Rebulla P, et al. Role of acetate during platelet storage in a synthetic medium. Transfusion 1992;32:152–6.10.1046/j.1537-2995.1992.32292180145.x1542920Search in Google Scholar

Guppy M, Whisson ME, Sabaratnam R, et al. Alternative fuels for platelet storage: a metabolic study. Vox Sang 1990;59:146–52.10.1111/j.1423-0410.1990.tb00849.x2264317Search in Google Scholar

Murphy S. The oxidation of exogenously added organic anions by platelets facilitates maintenance of pH during their storage for transfusion at 22°C. Blood 1995;85:1929–35.10.1182/blood.V85.7.1929.bloodjournal8571929Search in Google Scholar

Cesar J, DiMinno G, Alam I, et al. Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion. Transfusion 1987;27: 434–7.10.1046/j.1537-2995.1987.27587320540.x3629676Search in Google Scholar

Gawaz M, Ott I, Reininger AJ, et al. Effects of magnesium on platelet aggregation and adhesion. Thromb Haemost 1994;72:912–8.10.1055/s-0038-1648983Search in Google Scholar

Weis-Fogh US. The effect of citrate, calcium, and magnesium ions on the potassium movement across the human platelet membrane. Transfusion 1985;25:339–42.10.1046/j.1537-2995.1985.25485273813.x4024232Search in Google Scholar

Kinlough-Rathbone RL, Packham MA, Mustard JF. Platelet aggregation. In: Harker LA, Zimmerman TS, eds. Methods of hematology: measurements of platelet function. New York: Churchill Livingstone, 1984:64–91.Search in Google Scholar

Gulliksson H. Storage of platelets in additive solutions: the effect of citrate and acetate in in vitro studies. Transfusion 1993;33:301–3.10.1046/j.1537-2995.1993.33493242636.x8480349Search in Google Scholar

de Wildt-Eggen J, Schrijver JG, Bins M, et al. Storage of platelets in additive solutions: effects of magnesium and potassium. Transfusion 2000;42: 76–80.10.1046/j.1537-2995.2002.00012.x11896316Search in Google Scholar

Gulliksson H, AuBuchon JP, Vesterinen M, et al. Storage of platelets in additive solutions: a pilot study of the effects of potassium and magnesium. In vitro studies. Vox Sang 2002;82:131–6.10.1046/j.1423-0410.2002.drfgv158.x11952987Search in Google Scholar

Gulliksson H, AuBuchon JP, Cardigan R, et al. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang 2003;85: 199–205.10.1046/j.1423-0410.2003.00356.x14516450Search in Google Scholar

Hunter S, Nixon J, Murphy S. The effect of the interruption of agitation on platelet quality during storage for transfusion. Transfusion 2001;41: 809–14.10.1046/j.1537-2995.2001.41060809.x11399825Search in Google Scholar

van der Meer PF, Gulliksson H, AuBuchon JP, et al. Interruption of agitation of platelet concentrates: effects on in vitro parameters. Vox Sang 2005; 88:227–34.10.1111/j.1423-0410.2005.00621.x15877643Search in Google Scholar

eISSN:
1930-3955
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Laboratoriumsmedizin